Page last updated: 2024-09-03

almotriptan and Hypomenorrhea

almotriptan has been researched along with Hypomenorrhea in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acuto, G; Allais, G; Allais, R; Benedetto, C; Bussone, G; D'Andrea, G; d'Onofrio, F; Grazzi, L; Manzoni, GC; Moschiano, F; Valguarnera, F1
Bartolini, M; Brighina, F; Ferrari, MD; Fierro, B; Giamberardino, MA; Lisotto, C; Martelletti, P; Moscato, D; Omboni, S; Panascia, B; Pini, LA; Sances, G; Santoro, P; Savi, L; Zanchin, G1

Trials

2 trial(s) available for almotriptan and Hypomenorrhea

ArticleYear
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
    Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Animals; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Placebos; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Young Adult

2011
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
    The journal of headache and pain, 2012, Volume: 13, Issue:5

    Topics: Adult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines

2012